Ratings Tae Kwang Corporation

Equities

A023160

KR7023160005

End-of-day quote Korea S.E. 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
12,450 KRW -2.66% Intraday chart for Tae Kwang Corporation +2.64% -15.48%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The company returns high margins, thereby supporting business profitability.
  • Its low valuation, with P/E ratio at 6.39 and 4.91 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company appears to be poorly valued given its net asset value.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Industrial Machinery & Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
-15.48% 231M -
+16.47% 8.56B
B+
+20.64% 6.46B -
C+
+14.10% 5B
C+
+5.57% 4.65B
C
+22.65% 4.3B
A-
-14.49% 3.27B -
-22.55% 2.77B -
-1.49% 2.5B
A-
-4.69% 2.45B
D
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A023160 Stock
  4. Ratings Tae Kwang Corporation